TC
EBS icon

TFS Capital’s Emergent Biosolutions EBS Stock Holding History

TFS Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-30,350
Closed -$1.03M – 107
2017
Q2 		$1.03M Sell
30,350
-6,562
-18% -$203K 0.4% 18
2017
Q1 		$1.07M Buy
+36,912
New +$1.12M 0.35% 85
2016
Q4 		– Sell
-54,512
Closed -$1.72M – 767
2016
Q3 		$1.72M Buy
54,512
+39,567
+265% +$1.15M 0.41% 52
2016
Q2 		$420K Sell
14,945
-11,741
-44% -$460K 0.08% 424
2016
Q1 		$970K Sell
26,686
-169,636
-86% -$5.99M 0.14% 262
2015
Q4 		$7.86M Buy
196,322
+124,081
+172% +$4.33M 0.85% 1
2015
Q3 		$2.06M Buy
72,241
+61,901
+599% +$2.04M 0.2% 151
2015
Q2 		$341K Sell
10,340
-138,978
-93% -$4.31M 0.03% 639
2015
Q1 		$4.29M Buy
149,318
+15,963
+12% +$458K 0.42% 39
2014
Q4 		$3.63M Buy
133,355
+90,374
+210% +$2.15M 0.35% 53
2014
Q3 		$916K Buy
+42,981
New +$984K 0.08% 401
2014
Q2 		– Sell
-34,575
Closed -$874K – 1178
2014
Q1 		$874K Sell
34,575
-52,224
-60% -$1.32M 0.06% 515
2013
Q4 		$2M Sell
86,799
-26,747
-24% -$558K 0.09% 316
2013
Q3 		$2.16M Buy
113,546
+8,348
+8% +$149K 0.1% 300
2013
Q2 		$1.52M Buy
+105,198
New +$1.52M 0.06% 443

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

TFS Capital's EBS Position: Q3 2017 in Review

TFS Capital sold out of Emergent Biosolutions (EBS) in Q3 2017, closing a stake of 30,350 shares — an estimated $1.03M sold.

TFS Capital first reported a position in EBS in Q2 2013 and held it in 15 quarters. The position peaked at $7.86M in Q4 2015. 198 funds tracked by Wall St. Rank hold EBS as of Q3 2017.

  • TFS Capital reported no remaining Emergent Biosolutions position as of Q3 2017 after selling out during the quarter.
  • TFS Capital sold 30,350 Emergent Biosolutions shares in Q3 2017, an estimated $1.03M.
  • TFS Capital first reported a position in Emergent Biosolutions in Q2 2013 and held it in 15 quarters.
  • TFS Capital's Emergent Biosolutions position peaked at $7.86M in Q4 2015.
  • 198 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.